Showing 1 - 10 of 16
Persistent link: https://www.econbiz.de/10003304750
Persistent link: https://www.econbiz.de/10009500075
Persistent link: https://www.econbiz.de/10011433285
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...
Persistent link: https://www.econbiz.de/10008749029
Persistent link: https://www.econbiz.de/10009270541
Persistent link: https://www.econbiz.de/10001737359
Persistent link: https://www.econbiz.de/10001755203
Persistent link: https://www.econbiz.de/10012586875
We analyse the effect of competition on quality in hospital markets with regulated prices, considering both the effect of (i) introducing competition (monopoly versus competition) and (ii) increasing competition through lower transportation costs (increased substitutability) or a higher number...
Persistent link: https://www.econbiz.de/10013152862
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...
Persistent link: https://www.econbiz.de/10013017702